Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

Hydrogen Inhalation Helps Gallbladder Cancer Patient Achieve Remission

<p>A Gallbladder Carcinoma Patient With Pseudo-Progressive Remission After Hydrogen Inhalation</p>

Research hubs: Digestive System · Immune System

Scientific visualization of hydrogen therapy research for <p>A Gallbladder Carcinoma Patient With Pseudo-Progressive Remission After Hydrogen Inhalation</p>
Evidence type
Case report or series · Human study
Authors
Ji-Bing Chen, Feng Mu, Tianyu Lu, Yangyang Ma, Duanming Du, Ke-Cheng Xu
Journal
OncoTargets and Therapy
Year
2019
Study Type
Human
Participants
1
Delivery
Gas
Dose
hydrogen inhalation therapy for approximately one month with continued monitoring over 10+ months
Duration
10 months
Conflicts of interest
None declared
Outcome
Positive
Peer Reviewed
Yes
Cited by
16 (OpenAlex, as of November 2026)
Country
China

TL;DR

Inhaling hydrogen gas helped a patient with advanced gallbladder cancer by initially making the tumors look worse before they actually started to shrink, leading to an improvement in the patient's health and prolonged survival.

Key Finding

A patient with metastatic gallbladder cancer experienced initial tumor growth followed by sustained remission after hydrogen inhalation therapy, a pattern similar to pseudo-progression seen with PD-1 immunotherapy drugs.

Summary

A 72-year-old woman with advanced gallbladder cancer that had spread to other organs received hydrogen gas therapy along with standard supportive care. Initially, her tumors appeared to grow larger and tumor markers (blood tests indicating cancer activity) increased, but then the tumors began shrinking over the following weeks. Her symptoms improved, blood counts normalized, and she was able to return to normal activities for over 10 months. This pattern—where tumors temporarily appear worse before improving—resembles what sometimes happens with certain cancer immunotherapy drugs.

Practical Takeaway

This is a single case report, not a controlled study, so it cannot establish whether hydrogen therapy caused the improvement or whether this would occur in other patients. The authors suggest hydrogen may affect immune cell function in ways similar to established cancer drugs, but this remains speculative. Much more rigorous research would be needed before drawing any conclusions about hydrogen's role in cancer treatment.

Abstract (excerpt)

Background: Hydrogen therapy has been reported to convert exhausted programmed cell death receptor (PD-1)+CD8+ T cells to PD-1-CD8+ T cells, in advanced colorectal cancer patients, which is associated with significantly prolonged survival. Case presentation: A 72-year-old female patient presented…

Read the full abstract on PubMed